H.J.T. Rutten

Vande Kerckhove, F. E. C., Piqeur, F., Banken, E., Morsink, N. C., Rijkaart, D. C., Cnossen, J. S., Tijssen, R. H. N., Huibregtse Bimmel-Nagel, C. C. A., van Hellemond, I. E. G., Nederend, J., Rutten, H. J. T., Bloemen, J. G., Burger, J. W. A., Verrijssen, A. E., & Peulen, H. M. U. (2025). Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancer. Radiation Oncology, 21(1), Article 21. https://doi.org/10.1186/s13014-025-02782-w

Vande Kerckhove, F. E. C., van den Berg, K., van Erning, F. N., Daniels-Gooszen, A. W., Verrijssen, A. E., Peulen, H. M. U., Rutten, H. J. T., van Hellemond, I. E. G., Bloemen, J. G., Burger, J. W. A., Nederend, J., Tolenaar, J. L., & Ketelaers, S. H. J. (2025). Implications of inaccurate lymph node staging in early and intermediate-risk rectal cancer on survival-related outcomes in a large Dutch population-based cohort. European Journal of Cancer, 231, Article 116052. https://doi.org/10.1016/j.ejca.2025.116052

Banken, E., Geubels, B. M., Vande Kerckhove, F. E. C., Creemers, D. M. J., Ketelaers, S. H. J., Nederend, J., Peulen, H. M. U., van Hellemond, I. E. G., Rutten, H. J. T., & Burger, J. W. A. (2025). Watch-and-wait approach in high-risk locally advanced rectal cancer: outcomes after complete response to total neoadjuvant therapy. BJS Open, 9(6), Article zraf136. https://doi.org/10.1093/bjsopen/zraf136

Creemers, D. M. J., Mens, D. M., Nordkamp, S., Piqeur, F., Banken, E., Ketelaers, S. H. J., Harmsen, P. W., Tolenaar, J. L., van Hellemond, I. E. G., Creemers, G. M., Verheul, H. M. W., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Nederend, J., Verrijssen, A. E., Peulen, H. M. U., Rothbarth, J., Coebergh-van den Braak, R. R. J., Rutten, H. J. T., ... Burger, J. W. A. (2025). Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort. European Journal of Surgical Oncology, 51(9), Article 110261. https://doi.org/10.1016/j.ejso.2025.110261

Warmerdam, M. I., Creemers, D. M. J., Kusters, M., Peeters, K. C. M. J., Holman, F. A., Mieog, J. S. D., Cailler, F., Burger, P. J. W. A., Burggraaf, J., Rutten, H. J. T., Verhoef, C., Vahrmeijer, A. L., & Hilling, D. E. (2025). Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal Cancer. Molecular Imaging and Biology, 27(4), 629-637. https://doi.org/10.1007/s11307-025-02021-4

Creemers, D. M. J., Iversen, H., Banken, E., Piqeur, F., Ketelaers, S. H. J., Daniëls-Gooszen, A., Palmer, G. J., Holm, T., Rutten, H., Suzuki, C., Burger, J. W. A., Martling, A., & Nederend, J. (2025). Association of Pelvic Structure Involvement and Tumor Morphology at MRI with Prognosis Following Resection in Locally Recurrent Rectal Cancer. Radiology. Imaging cancer, 7(4), Article e240246. https://doi.org/10.1148/rycan.240246

Piqeur, F., van Gruijthuijsen, D. S. C., Nederend, J., Ceha, H., Stam, T., Dieters, M., Meijnen, P., Bakker-van der Jagt, M., Intven, M., Verrijssen, A. E., Cnossen, J. S., Berbee, M., Hartogh, M. D., Bantema-Joppe, E. J., De Kroon, M., Paardekooper, G., Gielens, M. P. M., Daniels-Gooszen, A. W., Lahaye, M. J., ... Peulen, H. (2025). Multidisciplinary approach to target volume delineation in locally recurrent rectal cancer: An explorative study. Clinical and Translational Radiation Oncology, 53, Article 100948. https://doi.org/10.1016/j.ctro.2025.100948

Banken, E., Creemers, D. M. J., Vande Kerckhove, F. E. C., Ketelaers, S. H. J., van Hellemond, I. E. G., Peulen, H. M. U., Rutten, H. J. T., & Burger, J. W. A. (2025). Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survival. European Journal of Surgical Oncology, 51(7), Article 109758. https://doi.org/10.1016/j.ejso.2025.109758

van den Berg, K., van Erning, F. N., Burger, J. W., van Hellemond, I. E., Roodhart, J. M., Koopman, M., Rutten, H. J., & Creemers, G.-J. (2025). Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The Netherlands. Clinical colorectal cancer, 24(2), 300-309. https://doi.org/10.1016/j.clcc.2025.02.006

van den Berg, K., Banken, E., van Rees, J. M., Coolen, L. M., de Vries, M., Voogt, E. L. K., Rothbarth, J., Rutten, H. J. T., Nederend, J., van Hellemond, I. E. G., Creemers, G. J. M., Verhoef, C., & Burger, J. W. A. (2025). Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres. European Journal of Surgical Oncology, 51(5), Article 109699. https://doi.org/10.1016/j.ejso.2025.109699